Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, July 26, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New Phenomenex GC Column Set for Chlorinated Pesticides
Friday, July 25, 2014
The Zebron ZB-CLPesticides GC column runs seven EPA methods.

Reliable Assays for Sugars in Acid-Hydrolyzed Wood
Friday, July 25, 2014
Determination of common sugars by high-performance anion-exchange chromatography with pulsed amperometric detection methods.

WHEATON® Highlights Products at AACC 2014
Thursday, July 24, 2014
The products to be featured at the meeting offer unique solutions for the clinical market.

Simultaneous Determination of Amlodipine and its Counterion Besylate
Friday, July 18, 2014
Determination of amlodipine and besylate by a simple, rapid, reliable, and accurate HPLC method.

Vanquish UHPLC sees Thermo Fisher Scientific Reimagine UHPLC
Tuesday, July 15, 2014
Thermo Fisher Scientific has unveiled a new high performance liquid chromatography system designed from the ground up to provide new levels of performance, productivity and usability when used as a standalone system or with the latest mass spectrometers.

Compact Sample Concentrator for R&D Departments
Tuesday, July 15, 2014
MiniVap™ blowdown sample concentrator from Porvair Sciences.

Rapid Determination of Myo-Inositol in Infant Formula and Adult Nutritionals
Saturday, July 12, 2014
Determination of myo-inositol by a high-performance anion-exchange chromatography with pulsed amperometric detection method.

High Vacuum Benchtop Solvent Evaporator
Friday, July 11, 2014
The EZ-2 Elite Centrifugal Evaporator from Genevac.

Method Separates Oxidized Monoclonal Antibody (MAb) Species
Friday, July 04, 2014
Thermo Scientific™ ProPac™ HIC-10 column used to separate the papain fragments.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 752
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv